Technology ❯ Biotechnology

Gene Therapy

CRISPR CRISPR Applications Hearing Restoration CRISPR Technology Non-Viral Delivery Genome Editing Technologies CRISPR Systems Adeno-Associated Virus Regulatory Pathways Clinical Trials mRNA Technology Regenerative Medicine Medical Devices Mitochondrial Replacement Therapy Gene Silencing Genetic Research Genome Editing Techniques Transcription Factors Manufacturing Processes Medical Innovations Genome Editing Protein Synthesis Lipid Nanoparticles Organ Bioprinting Huntington's Disease CAR-T Therapy Viral Vectors Cell Engineering Cell Therapy ASO Technology Optogenetic Techniques Mitochondrial Therapy Ex Vivo Therapies In Vivo Editing

Lilly Acquires Engage Biologics for Up to $202 Million

The deal gives Lilly a preclinical Tethosome non‑viral DNA delivery platform, a lipid‑nanoparticle approach designed to target potency, tolerability and re‑dosing limits in DNA therapies.

Aurora Therapeutics Launches to Scale Bespoke Gene Editing for PKU

Prime Editing Tool PERT Debuts as Broad, One-Time Strategy for Nonsense Mutations

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

mRNA-Style Antiviral Mimics Rare Mutation to Block Viruses for Days in Rodents

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion